Sponsor or institution
Clinical trials and research at Circumvent Pharmaceuticals, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $3.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
NtBuHA therapy for CLN1 Batten disease
A new drug candidate, NtBuHA/CIRC827, is being developed to treat CLN1 Batten disease in children and teens.
-
CIRC827 (NtBuHA) — a potential treatment for CLN1 Batten disease
This project develops CIRC827 (NtBuHA), a new medicine aimed at treating children with CLN1 Batten disease.
-
Developing a new treatment for Infantile Neuronal Ceroid Lipofuscinosis (INCL)
This study is testing a new treatment called NtBuHA for children with Infantile Neuronal Ceroid Lipofuscinosis (INCL), a serious brain disorder, to see if it can help improve their health and quality of life.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.